We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 736 results
  1. Rutaecarpine Protects Against Cigarette Smoke–Induced Chronic Obstructive Pulmonary Disease (COPD) in Rats

    Abstract

    Chronic obstructive pulmonary disease (COPD) is a chronic lung inflammatory disease that causes restricted airflow and breathing...

    Zexuan Ji, Changhong Zhang, ... Jianqing Zhao in Applied Biochemistry and Biotechnology
    Article 14 March 2024
  2. Population Rearrangement of B Lymphocytes Expressing Chemokine Receptors in Patients with Chronic Obstructive Pulmonary Disease

    Abstract

    To date, there are no drugs that can prevent progressive destruction of lung tissue and small airway fibrosis in patients with chronic...

    A. G. Kadushkin, A. D. Tahanovich, ... T. V. Shman in Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry
    Article 15 August 2022
  3. Knockdown of circ_0006872 alleviates CSE-induced human bronchial epithelial cells injury in chronic obstructive pulmonary disease

    Circular RNAs (circRNAs) have been reported to be related to the initiation and progression of chronic obstructive pulmonary disease (COPD) by...

    Jieqiong Wang, Zegeng Li, ... Chuanbo Wang in Applied Biological Chemistry
    Article Open access 22 February 2023
  4. ceRNA Network Analysis Reveals Potential Key miRNAs and Target Genes in COVID-19-Related Chronic Obstructive Pulmonary Disease

    The continued spread of SARS-CoV-2 has presented unprecedented obstacles to the worldwide public health system. Especially, individuals with chronic...

    Lihai Zhang, **aodong Jia, ... Lindong Yuan in Applied Biochemistry and Biotechnology
    Article 10 November 2023
  5. The Effect of Glucocorticoids in Combination with Azithromycin or Theophylline on Cytokine Production by NK and NKT-Like Blood Cells of Patients with Chronic Obstructive Pulmonary Disease

    Abstract

    Chronic obstructive pulmonary disease (COPD) is characterized by reduced sensitivity of cells to the anti-inflammatory effects of...

    A. G. Kadushkin, A. D. Tahanovich, ... T. V. Shman in Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry
    Article 01 October 2021
  6. Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review

    Oxidative stress is significantly involved in the pathogenesis and progression of chronic obstructive pulmonary disease (COPD). Combining antioxidant...

    You Xu, Hongmei Liu, Lei Song in Journal of Nanobiotechnology
    Article Open access 19 October 2020
  7. Biological Influence of Pulmonary Disease Conditions Induced by Particulate Matter on Microfluidic Lung Chips

    Particulate matter (PM10)-induced respiratory illnesses are difficult to investigate in trans-well culture systems. Microphysiological systems offer...

    Faiza Jabbar, Young-Su Kim, Sang Ho Lee in BioChip Journal
    Article 08 July 2022
  8. Novel inhalation therapy in pulmonary fibrosis: principles, applications and prospects

    Pulmonary fibrosis (PF) threatens millions of people worldwide with its irreversible progression. Although the underlying pathogenesis of PF is not...

    Meiling Zheng, Wei Zhu, ... Cuiling Feng in Journal of Nanobiotechnology
    Article Open access 29 March 2024
  9. Nanomedicine Applied to Inflammatory and Infectious Pulmonary Diseases

    Chronic pulmonary diseases often include inflammation in the upper or lower respiratory tract causing severe/extreme discomfort. To subside...
    Arshdeep Kaur, Rishika Sharma, ... Gopinath Packirisamy in Biotechnology Applied to Inflammatory Diseases
    Chapter 2023
  10. miR-221-3p is upregulated in acute pulmonary embolism complicated with pulmonary hypertension and promotes pulmonary arterial smooth muscle cells proliferation and migration by inhibiting PTEN

    Pulmonary arterial smooth muscle cells (PASMCs) functions are associated with the pathogenesis of pulmonary hypertension (PH) which is a...

    Lei Tang, Shuai Niu, ... Li Zhou in Cytotechnology
    Article 29 April 2024
  11. Nano-Based Therapies for Acute and Chronic Lung Diseases

    Nanotechnology in medicine—known as nanomedicine—has opened a new era for accurate and precise diagnosis and treatment of pulmonary inflammatory...
    Mohammad Doroudian, Michelle E. Armstrong, Seamas C. Donnelly in Biotechnology Applied to Inflammatory Diseases
    Chapter 2023
  12. Ultra-processed food consumption and risk of chronic respiratory diseases mortality among adults: evidence from a prospective cohort study

    Purpose

    The purpose of the study was to determine the relationships between ultra-processed food (UPF) consumption and risk of mortality due to...

    Tefera Chane Mekonnen, Yohannes Adama Melaku, ... Tiffany K. Gill in European Journal of Nutrition
    Article Open access 28 February 2024
  13. Guardians Turned Culprits: NETosis and Its Influence on Pulmonary Fibrosis Development

    Idiopathic pulmonary fibrosis (IPF) is a debilitating, life-threatening irreversible lung disease characterized by the excessive accumulation of...

    Aleena Varughese, Akarsha Balnadupete, ... Yashodhar Bhandary in Molecular Biotechnology
    Article 08 May 2024
  14. Extracellular vesicles in venous thromboembolism and pulmonary hypertension

    Venous thromboembolism (VTE) is a multifactorial disease, and pulmonary hypertension (PH) is a serious condition characterized by pulmonary vascular...

    Jiwei Zhang, **aoyi Hu, ... Qinghua Hu in Journal of Nanobiotechnology
    Article Open access 30 November 2023
  15. Nanomaterials-assisted gene editing and synthetic biology for optimizing the treatment of pulmonary diseases

    The use of nanomaterials in gene editing and synthetic biology has emerged as a pivotal strategy in the pursuit of refined treatment methodologies...

    Lanjie Lei, Wenjie Pan, ... Liyun Shi in Journal of Nanobiotechnology
    Article Open access 18 June 2024
  16. Tuberculosis: Cellular Understanding of Disease

    Tuberculosis is undoubtedly a public health concern. An understanding of the cellular make-up of the disease can help in its mitigation by several...
    Nana Mireku-Gyimah, Nana Ama Mireku-Gyimah in Tubercular Drug Delivery Systems
    Chapter 2023
  17. Pharmacokinetics of Nanoparticle Systems for Pulmonary Delivery

    The introduction of nanotechnology in the pharmaceutical field has incited the attention of researchers to develop nanoparticle-based formulations to...
    Bhupendra Prajapati, Himanshu Paliwal, Jayvadan Patel in Pharmacokinetics and Pharmacodynamics of Nanoparticulate Drug Delivery Systems
    Chapter 2022
  18. Evaluation of Serum LECT2 and Sclerostin Levels in Patients Followed up for Obstructive Sleep Apnea

    Abstract

    Background: Obstructive sleep apnea (OSA) is characterized by recurrent apnea/hypopnea in the upper airways and oxygen desaturation...

    Buğra Kerget, Gizem Çil, ... Esra Laloglu in Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry
    Article 01 September 2023
  19. MAP3K19 Promotes the Progression of Tuberculosis-Induced Pulmonary Fibrosis Through Activation of the TGF-β/Smad2 Signaling Pathway

    Tuberculosis-induced pulmonary fibrosis (PF) is a chronic, irreversible interstitial lung disease, which severely affects lung ventilation and air...

    Yu **a, Haiyue Wang, ... Feng Sun in Molecular Biotechnology
    Article 31 October 2023
  20. Obesity: A Disease of Overnutrition

    Obesity is a serious worldwide problem that is increasing in prevalence. Obesity results from increased energy intake from food exceeding what is...
    George A. Bray, Catherine M. Champagne in Nutritional Health
    Chapter 2023
Did you find what you were looking for? Share feedback.